Repetitive High-Dose Topotecan, Carboplatin, and Paclitaxel with Peripheral Blood Progenitor Cell Support in Previously Untreated Ovarian Cancer: Results of a Phase I Study

Author： Prince H.M.   Rischin D.   Quinn M.   Allen D.   Planner R.   Neesham D.   Gates P.   Davison J.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.81, Iss.2, 2001-05, pp. : 216-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pilot Evaluation of High-Dose Carboplatin and Paclitaxel Followed by High-Dose Melphalan Supported by Peripheral Blood Stem Cells in Previously Untreated Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

By Schilder R.J.   Brady M.F.   Spriggs D.   Shea T.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 3-8

Academic Press

Access to resources Recommend Favorite

Phase I Study of Alternating Doublets of Topotecan/Carboplatin and Paclitaxel/Carboplatin in Patients with Newly Diagnosed, Advanced Ovarian Cancer

By Gordon A.N.   Hancock K.C.   Matthews C.M.   Messing M.   Stringer C.A.   Doherty M.G.   Teneriello M.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 129-135

Elsevier

Access to resources Recommend Favorite

A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

By Kallab Andre   Nalamolu Yasolatha   Dainer Paul   Jillella Anand  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 145-151

Humana Press, Inc

Access to resources Recommend Favorite

A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer

By Gluck S.   Germond C.   Lopez P.   Cano P.   Dorreen M.   Koski T.   Arnold A.   Dulude H.   Gallant G.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1008-1014

Elsevier

Access to resources Recommend Favorite

A Phase I Study of Paclitaxel, Doxorubicin, and Cisplatin in Patients with Previously Untreated Epithelial Ovarian Cancer

By Naumann R.W.   Alvarez R.D.   Omura G.A.   Segars E.   Kilgore L.C.   Partridge E.E.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 450-453

Elsevier

Access to resources Recommend Favorite